Inventor

Maurice Raymond Verschoyle Finlay

Inventor
Macclesfield, GB

Overview

22→
Patents
2004–2021
Patent span
Human necessities
Primary field (CPC A)

Patents· 22 as inventor

Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.

C07Dprimary
C07DHeterocyclic compounds35%
A61PSpecific therapeutic activity of chemical compounds or medicinal preparations33%
A61KPreparations for medical, dental or toiletry purposes27%
C07BGeneral methods of organic chemistry3%
Y02PClimate change mitigation technologies in the production or processing of goods2%
PatentTitleYear
10,981,9041,3,4-thiadiazole compounds and their use in treating cancer202110,858,3362-(2,4,5-substituted-anilino)pyrimidine compounds202010,577,354Bis-pyridazine compounds and their use in treating cancer202010,407,446Amino-triazolopyridine compounds and their use in treating cancer201910,323,0281,3,4-thiadiazole compounds and their use in treating cancer201910,294,2211, 3, 4-thiadiazole compounds and their use in treating cancer201910,196,382bis-Pyridazine compounds and their use in treating cancer201910,040,7881,3,4-thiadiazole compounds and their use in treating cancer201810,040,7891,3,4-thiadiazole compounds and their use in treating cancer201810,017,4932-(2,4,5-substituted-anilino)pyrimidine compounds20189,938,2651,3,4-thiadiazole compounds and their use in treating cancer20189,732,058'2-(2,4,5-substituted-anilino)pyrimidine compounds'20178,946,235'2-(2,4,5-substituted-anilino) pyrimidine compounds'20157,750,003'Compounds-943'20107,745,428'Imidazo[1,2-A]pyridine having anti-cell-proliferation activity'20107,655,652'Imidazolo-5-yl-2-anilinopyrimidines as agents for the inhibition of cell proliferation'20107,579,366'Epothilone derivatives and their synthesis and use'20097,485,644'N-{\'4-substituted piperazine-1-sulfonylmethylalkyl}-n-hydroxyfomamide compounds as metalloproteinase inhibitors'20097,173,137'Epothilone analogs'20077,153,857'Arylpiperazines and arylpiperidines and their use as metalloproteinase inhibiting agents'20067,122,551'Metalloproteinase inhibitor compounds'20066,734,183'Compounds'2004

Career & activity timeline

Assembled from patent assignee/location history and declaration credentials.

2004–2020Patents assigned to ASTRAZENECA AB (18)· patent assignee history
2004–2020Based in Macclesfield, GB· patent location history
2006–2015Based in Cheshire, GB· patent location history
2007–2009Patents assigned to SCRIPPS RESEARCH INST (2)· patent assignee history
2015Patents assigned to BUTTERWORTH SAM (1)· patent assignee history
2018–2021Patents assigned to CANCER RESEARCH TECH LTD (9)· patent assignee history
2018–2021Based in Cambridge, GB· patent location history
2020Patents assigned to ASTAZENECA AB (1)· patent assignee history

Inventor activity

Assignee and location history derived from the patent record.

Assignees
AssigneePatentsSpan
ASTRAZENECA AB182004–2020
CANCER RESEARCH TECH LTD92018–2021
SCRIPPS RESEARCH INST22007–2009
ASTAZENECA AB12020
BUTTERWORTH SAM12015
Locations
LocationPatentsSpan
Macclesfield, GB112004–2020
Cambridge, GB92018–2021
Cheshire, GB22006–2015